Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $131000.0.

  • Dna X's Net Cash Flow rose 12425.93% to $131000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 83934.87%. This contributed to the annual value of -$4.1 million for FY2024, which is 623.69% down from last year.
  • Latest data reveals that Dna X reported Net Cash Flow of $131000.0 as of Q3 2025, which was up 12425.93% from -$109000.0 recorded in Q2 2025.
  • In the past 5 years, Dna X's Net Cash Flow registered a high of $7.5 million during Q2 2022, and its lowest value of -$8.2 million during Q1 2021.
  • Its 5-year average for Net Cash Flow is -$1.1 million, with a median of -$400000.0 in 2023.
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 20725.48% in 2022, then crashed by 212620.69% in 2025.
  • Quarter analysis of 5 years shows Dna X's Net Cash Flow stood at $1.0 million in 2021, then tumbled by 316.16% to -$2.3 million in 2022, then soared by 82.31% to -$400000.0 in 2023, then plummeted by 829.25% to -$3.7 million in 2024, then surged by 103.52% to $131000.0 in 2025.
  • Its Net Cash Flow stands at $131000.0 for Q3 2025, versus -$109000.0 for Q2 2025 and -$3.2 million for Q1 2025.